Accendra Health, Inc. earnings per share and revenue
On --, ACH reported earnings of -- USD per share (EPS) for -- --, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q4 25, -- analysts forecast an EPS of 0.22 USD, with revenue projected to reach 721.88 million USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
$0.01
Surprise
0.00%
Abbott Laboratories
Report Date
Jan 22, 2026 For Q4 25
Estimate
$1.51
Actual
$1.50
Surprise
-0.75%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
FAQ
What were Accendra Health, Inc.'s earnings and revenue for the latest quarter Q-- --?
For Q-- --, Accendra Health, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Accendra Health, Inc.'s Q-- -- earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Accendra Health, Inc. expected to report next?
The next earning report is scheduled for Feb 25, 2026.
What are the forecasts for Accendra Health, Inc.'s next earnings report?
Based on --
analysts, Accendra Health, Inc. is expected to report EPS of $0.22 and revenue of $721.88M for Q4 2025.